3918 related articles for article (PubMed ID: 20441712)
1. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
2. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
3. Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation.
Scotland G; Cruickshank M; Jacobsen E; Cooper D; Fraser C; Shimonovich M; Marks A; Brazzelli M
Health Technol Assess; 2018 Jan; 22(1):1-138. PubMed ID: 29298736
[TBL] [Abstract][Full Text] [Related]
4. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.
Zhang AH; Tam P; LeBlanc D; Zhong H; Chan CT; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2009 Dec; 41(4):977-82. PubMed ID: 19578968
[TBL] [Abstract][Full Text] [Related]
5. A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy.
Gallagher H; Methven S; Casula A; Thomas N; Tomson CR; Caskey FJ; Rose T; Walters SJ; Kennedy D; Dawnay A; Cassidy M; Fluck R; Rayner HC; Nation M
BMC Nephrol; 2017 Apr; 18(1):131. PubMed ID: 28399810
[TBL] [Abstract][Full Text] [Related]
6. Nephrology consultation and kidney failure in people with stage 4 chronic kidney disease: a population-based cohort study.
Liu P; Quinn RR; Cortese G; Mahsin M; James MT; Ronksley PE; Quan H; Manns B; Hemmelgarn BR; Tonelli M; Ravani P
J Nephrol; 2021 Aug; 34(4):1225-1234. PubMed ID: 33211302
[TBL] [Abstract][Full Text] [Related]
7. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
Smart NA; Dieberg G; Ladhani M; Titus T
Cochrane Database Syst Rev; 2014 Jun; (6):CD007333. PubMed ID: 24938824
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants for chronic kidney disease.
Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
[TBL] [Abstract][Full Text] [Related]
9. The kidney and cardiovascular outcome trials.
Bloomgarden Z
J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
11. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
[TBL] [Abstract][Full Text] [Related]
12. Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease.
Ricardo AC; Roy JA; Tao K; Alper A; Chen J; Drawz PE; Fink JC; Hsu CY; Kusek JW; Ojo A; Schreiber M; Fischer MJ;
J Gen Intern Med; 2016 Jan; 31(1):22-9. PubMed ID: 26138006
[TBL] [Abstract][Full Text] [Related]
13. Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study.
Tangri N; Peach EJ; Franzén S; Barone S; Kushner PR
Adv Ther; 2023 Jun; 40(6):2869-2885. PubMed ID: 37133647
[TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol for the treatment of chronic kidney disease: a systematic review.
Fleeman N; Pilkington G; Dundar Y; Dwan K; Boland A; Dickson R; Anijeet H; Kennedy T; Pyatt J
Health Technol Assess; 2014 Jun; 18(40):1-77, v-vi. PubMed ID: 24965683
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
